RenovoRx, Inc.
RNXT
$2.00
-$0.21-9.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 61.46% | 136.55% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 61.46% | 136.55% | |||
| Cost of Revenue | 70.24% | 200.00% | |||
| Gross Profit | 59.92% | 128.10% | |||
| SG&A Expenses | 7.17% | 21.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.61% | 23.68% | |||
| Operating Income | 3.46% | -14.79% | |||
| Income Before Tax | 17.32% | -19.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 17.32% | -19.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 17.32% | -19.72% | |||
| EBIT | 3.46% | -14.79% | |||
| EBITDA | 3.58% | -14.80% | |||
| EPS Basic | 33.59% | -15.46% | |||
| Normalized Basic EPS | 33.68% | -39.18% | |||
| EPS Diluted | 33.59% | -15.46% | |||
| Normalized Diluted EPS | 33.68% | -39.18% | |||
| Average Basic Shares Outstanding | 24.36% | 3.75% | |||
| Average Diluted Shares Outstanding | 24.36% | 3.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||